Correction to: Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice (Targeted Oncology, (2021), 16, 5, (601-611), 10.1007/s11523-021-00826-1)

Adam Brufsky, Xianchen Liu, Benjamin Li, Lynn McRoy, Rachel M. Layman

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Correction to: Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice (Targeted Oncology, (2021), 16, 5, (601-611), 10.1007/s11523-021-00826-1)'. Together they form a unique fingerprint.

Medicine & Life Sciences